PI3K/Akt/mTOR pathway was found to regulate the proliferation, apoptosis, metastasis of lung cancer, and various drugs that inhibit the PI3K axis are currently being tested in a series of clinical trials [35]. Here, AKT1 is linked to lung cancer.